Triple
T12172973
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | David Sinclair |
E290015
|
entity |
| Predicate | founded |
P104
|
FINISHED |
| Object |
Sirtris Pharmaceuticals
Sirtris Pharmaceuticals was a biotechnology company focused on developing drugs that target sirtuins and cellular pathways related to aging and metabolic diseases.
|
E967266
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Sirtris Pharmaceuticals | Statement: [David Sinclair, founded, Sirtris Pharmaceuticals]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Sirtris Pharmaceuticals Context triple: [David Sinclair, founded, Sirtris Pharmaceuticals]
-
A.
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
-
B.
Ariad Pharmaceuticals
Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
-
C.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
D.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
-
E.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Sirtris Pharmaceuticals Triple: [David Sinclair, founded, Sirtris Pharmaceuticals]
Generated description
Sirtris Pharmaceuticals was a biotechnology company focused on developing drugs that target sirtuins and cellular pathways related to aging and metabolic diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Sirtris Pharmaceuticals Target entity description: Sirtris Pharmaceuticals was a biotechnology company focused on developing drugs that target sirtuins and cellular pathways related to aging and metabolic diseases.
-
A.
Millennium Pharmaceuticals
Millennium Pharmaceuticals is a biotechnology company known for developing innovative cancer therapies, including the proteasome inhibitor bortezomib (Velcade) for multiple myeloma.
-
B.
Ariad Pharmaceuticals
Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
-
C.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
-
D.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
-
E.
Jazz Pharmaceuticals
Jazz Pharmaceuticals is a biopharmaceutical company specializing in developing and commercializing innovative medicines for sleep disorders, oncology, and rare diseases.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6ab4d6c00819095a9a7c35de83cfb |
completed | April 8, 2026, 7:23 p.m. |
| NER | Named-entity recognition | batch_69d915dab42881908e2580c631d4d1cf |
completed | April 10, 2026, 3:23 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f5f6a6de3081908e5e0030c081d5a4 |
completed | May 2, 2026, 1:05 p.m. |
| NEDg | Description generation | batch_69f603b639208190a284fcd7e88e9d54 |
completed | May 2, 2026, 2:01 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69f60491eaec8190a16472fd37740ea0 |
completed | May 2, 2026, 2:05 p.m. |
Created at: April 8, 2026, 9:50 p.m.